Skip to content

The results are in: CRAs love CRIO

Over 13,000 protocols have gone through the CRIO system, and in the vast majority of them, CRAs have used CRIO to monitor source. We’ve always heard from our sites that their CRAs love the system, but now we have proof. According to a third party survey of CRAs who have used CRIO, by a healthy margin, CRAs agree that our system elevates the performance of the site, the CRAs themselves, and the study sponsors.


About the survey

CRIO retained a third party market research firm to conduct a web-based survey of Clinical Research Associate (CRA) users with recent logins to the CRIO system. The firm solicited participation from 03/16/2022 to 03/30/2022 to an anonymous web survey. The survey received a total of 79 responses. All users were assured of anonymity, and CRIO did not have access to the identifying information of any respondents.

Overall, the survey garnered excellent feedback from CRAs who use CRIO. In our survey, we asked if CRAs agreed or disagreed with various statements.

Here’s what the CRAs said:

Sponsors would benefit if more sites use CRIO (9:1)

By a 9:1 margin, more CRAs agree than disagree that sponsors would benefit if more sites utilized the CRIO eSource system or a system like it.

CRIO’s system enables sponsors to collect high quality data and ensure patient safety. This is because the system is designed to enforce protocol compliance at point of capture through edit checks and other automation features. Read our findings on how CRIO reduces protocol deviations by 40% and FDA audit risk by 70%.


CRIO is easy to use (5:1)

By a 5:1 margin, more CRAs agree than disagree that CRIO is easy to use and navigate.

CRAs find our eSource system extremely intuitive and require very little training to start using it. An eSource that is easy to navigate allows them to find data quickly to issue and close queries, thus being more productive.


CRIO increases efficiency (4:1)

By a 4:1 margin, more CRAs agree than disagree that CRIO allows them to perform their job more quickly.

With eSource, CRAs have all study documents available to them from anywhere in real time. This is why our survey responses cited CRIO as the most commonly used tool for remote monitoring. With remote monitoring, CRAs can save valuable time without having to travel, and can increase their efficiency in the comfort of their home office. They can find source data quickly and issue and close queries without needing to flip back and forth through paper binders.

Read this first-hand account about how a major CRO utilized CRIO eSource to perform remote monitoring during the pandemic, and how this technology enabled their team to hit critical metrics.


CRIO sites produce higher quality data (3:1)

By a 3:1 margin, more CRAs agree than disagree that the data in CRIO’s eSource is of higher quality.

CRIO’s eSource is built to provide a logical workflow for coordinators to conduct each visit. Sites can configure every question with instructions and built-in alerts that will immediately catch entry errors, protocol deviations, and possible adverse events indicated by out-of-range values. CRIO’s eConsent integrates with eSource so that the ICF version tracking triggers re-consent in the eSource itself. In addition, the audit trail is automatically generated every time data is changed after saving. This provides a blueprint behind the visit for CRAs to review. CRAs thus gain more insight into what is happening at each visit.

Ultimately, CRAs’ positive reviews of CRIO reflect better experiences by sites who use CRIO and sponsors of those sites. A smarter and easier eSource system optimizes workflows for everyone to recruit more patients, conduct more visits, and generate better quality data.

CRIO favicon by Team CRIO
Share this post
You may also find interesting
Explore our Blog
Progress notes are vital to source data Running a Study

Progress Notes are Vital to Source Data

Progress notes are free-text entries by the investigator, coordinator or study team member that are inserted into the source record. Generally, these play a critical and highly undervalued role in the study process. Progress notes are often used to: Clarify or confirm any data points that may appear as outliers, even before a query is...

Hand of businessman using smart phone with coin icon, technology, clinical trials operations Running a Study

Sponsors, Funding is Tight – Be Smart with Your Money

Getting a new product to market is expensive. There are a variety of studies and research that point to a wide array of costs, but generally speaking, it costs nearly $3 billion dollars to bring a new drug to market. Yes, you read that correctly. Beyond this, the success rate of a new compound to...

DCT Draft Guidance explained Running a Study

The FDA’s Decentralized Clinical Trials Draft Guidance Explained

The highly anticipated Decentralized Clinical Trials (DCT) draft guidance from the FDA was finally released on 02-May-2023. In this 19-page document, the FDA outlines its current thinking around the concept of DCTs. From the outset of the draft guidance, the FDA makes a clear point on what DCTs can mean for patients and the patient...